跳至主要内容
临床试验/DRKS00024952
DRKS00024952招募中未知

MOODSTRATIFICATION-IMMUNOSTRATA: Physical training intervention, premature immune aging and major mood disorders - MOODSTRATIFICATION-IMMUNOSTRATA

Klinik für Psychiatrie und Psychotherapie II der Universität Ulm0 个研究点目标入组 80 人开始时间: 2021年4月13日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Inclusion criteria for patients with MDD:
  • - Depressive episode in a unipolar or bipolar affective disorder
  • - HDRS-17 - value> 13
  • - Age 18-65
  • - Thoughts of the patient with an antidepressant and / or mood-stabilizing medication that does not work reliably
  • - Ability to give consent and IC

排除标准

  • Taking beta blockers
  • - Anomalies in the EKG
  • - Long-term use of anti-inflammatory drugs
  • - Existing or planned pregnancy or breastfeeding
  • - Schizoaffective disorder, schizophrenia
  • - Increased risk of suicidal behavior
  • - Chronic uncontrolled systemic or metabolic disease (e.g. diabetes mellitus)
  • - Other significant chronic, uncontrolled somatic, organic, neurological diseases that affect mood
  • - Current or past (last four weeks) somatic medication that affects the immune system or mood (corticosteroids, anti-inflammatory medication, immunosuppressants)
  • - Inability to complete the study program
  • - Patients who are related to employees or who have the same employment relationship

研究者

发起方
Klinik für Psychiatrie und Psychotherapie II der Universität Ulm

相似试验